Search for Clinical Trial Results
Heparin-induced Thrombocytopenia - 25 Studies Found
Status | Study |
Completed |
Study Name: Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II Condition: Heparin-induced Thrombocytopenia Type II Date: 2009-03-12 Interventions: Drug: argatroban |
Terminated |
Study Name: Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia Condition: Heparin-induced Thrombocytopenia Date: 2012-05-11 Interventions: Drug: Rivaroxaban Rivaroxaban 15 mg bid until HIT excluded by local laboratory assay or platelets recove |
Recruiting |
Study Name: Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) Condition: Heparin-induced Thrombocytopenia Date: 2017-05-01 Interventions: Drug: Warfarin, NOAC duration of treatment |
Completed |
Study Name: Heparin Induced Thrombocytopenia: Pharmacoeconomics Condition: Heparin Induced Thrombocytopenia (HIT) Date: 2007-04-02 |
Completed |
Study Name: Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients Condition: Heparin-induced Thrombocytopenia (HIT) Date: 2013-08-01 Interventions:
|
Not yet recruiting |
Study Name: Optimizing the Diagnosis of Heparin Induced Thrombocytopenia Condition: Heparin-induced Thrombocytopenia (HIT) Date: 2017-04-10 Interventions: Diagnostic Test: Diagnostic algorithm The treating physician will complete an enrollment assessment incl |
Completed |
Study Name: Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients Condition:
|
Terminated |
Study Name: A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome Condition: Suspected Heparin-Induced Thrombocytopenia Date: 2008-11-06 Interventions: Drug: Desirudin or Argatroban® Desirudin 15mg SC Argatroban® IV dosing per Package Insert |
Completed |
Study Name: Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) Condition:
Date: 2002-08-14 Interventions: Drug: bivalirudin Bivalirudin therapy will be given as a 0.75-mg/kg intravenous bolus and 1.75-mg/kg/h i |
Recruiting |
Study Name: Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2 Condition: Heparin-induced Thrombocytopenia Date: 2015-06-03 Interventions: Procedure: Blood Draw A one time blood draw of 150 milliliters will be performed using a vein in the par |